logo
Plus   Neg
Share
Email

McDermott Explores Strategic Alternatives For Lummus Technology; Stock Surges

McDermott International Inc. (MDR) said that it is exploring strategic alternatives for Lummus Technology, while maintaining the strategic rationale of engineering, procurement and construction.

In the pre-market trade, MDR is trading at $2.30, up $0.73 or 46.50 percent.

McDermott has retained Evercore as the lead advisor on the strategic alternatives process for Lummus Technology.

The company said it recently received unsolicited approaches to acquire all or part of Lummus Technology, McDermott's technology business, with valuation exceeding $2.5 billion.

In addition, McDermott said its previously announced processes to sell the remaining portion of its pipe fabrication business and its industrial storage tank business are ongoing.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Department of Justice has reached a settlement agreement with a Texas-based Taco Bell franchise owner for immigration-related discrimination against certain employees. The settlement resolves the DOJ's investigation into whether MUY Brands LLC, and a related management company, MUY Consulting Inc., violated the Immigration and Nationality Act. Starbucks is gearing up for the upcoming holiday season by introducing its 2019 holiday flavors in U.S. grocery stores. The launch of the coffee giant's holiday line-up this year includes returning holiday favorites as well as a new item. Customers can now take home products that are making a comeback such as Starbucks Holiday Blend K-Cup and Ground Coffee, Peppermint Mocha Flavored Ground Coffee, Peekay International issued a recall of 7 ounce and 14 ounce packs containing Keshav Dry Apricot food treats as they contain undeclared allergens such as sulfites, according to a statement published by The U.S. Food and Drug Administration. Consumption of the product by those allergic or having severe sensitivity to sulfites could run the risk of serious or life-threatening allergic reactions.
Follow RTT
>